My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Ahluwalia Contracts (India) gains after winning orders
Sep 28,2016

The announcement was made during market hours today, 28 September 2016.

Meanwhile, the BSE Sensex was up 3.26 points, or 0.01%, to 28,226.96.

On BSE, so far 8,040 shares were traded in the counter, compared with average daily volume of 10,905 shares in the past one quarter. The stock hit a high of Rs 312.05 and a low of Rs 295 so far during the day. The stock hit a 52-week high of Rs 336.20 on 6 September 2016. The stock hit a 52-week low of Rs 210 on 25 February 2016. The stock had underperformed the market over the past 30 days till 27 September 2016, falling 3.09% compared with 1.15% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 8.30% as against Sensexs 5.55% rise.

The small-cap company has equity capital of Rs 13.40 crore. Face value per share is Rs 2.

Ahluwalia Contracts (India) said that the total order inflow during the financial year ending March 2017 (FY 2017) stands at Rs 1360.98 crore.

Meanwhile, Ahluwalia Contracts (India) announced after market hours yesterday, 27 September 2016, that is received letter from Executive Engineer, Construction Division-2, Building Construction Department (B.C.D.) Patna, to stop construction of International Convention Centre (ICC) and Police Headquarter Bhawan, Patna as per order of National Green Tribunal (NGT), Eastern Zone Bench, Kolkata. The NGT has directed that Patna Master Plan was not yet approved and the approval of the master plan is mandatory requirement under the Ministry of Environment & Forests (MoEF) Notification in respect of constructions with built-up area of 20000 square meters or more. The said order shall be applicable to all construction activities in Patna and its adjacent areas where the city is proposed to be expanded. The company said it expects the matter to be resolved soon by the State Government.

Net profit of Ahluwalia Contracts (India) rose 14.46% to Rs 21.53 crore on 15.84% rise in net sales to Rs 305.80 crore in Q1 June 2016 over Q1 June 2015.

Ahluwalia Contracts (India) is one of the leading civil contractors in India.

Powered by Capital Market - Live News

Balaji Telefilms spurts after board OKs scheme of arrangement
Sep 28,2016

Meanwhile, the BSE Sensex was up 21.97 points, or 0.08%, to 28,245.67.

On BSE, so far 4.45 lakh shares were traded in the counter, compared with average daily volume of 61,268 shares in the past one quarter. The stock hit a high of Rs 103 and a low of Rs 98 so far during the day. The stock hit a 52-week high of Rs 150.40 on 23 November 2015. The stock hit a 52-week low of Rs 82.95 on 15 September 2016. The stock had outperformed the market over the past 30 days till 27 September 2016, rising 6.06% compared with 1.15% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 15.90% as against Sensexs 5.55% rise.

The small-cap company has equity capital of Rs 15.19 crore. Face value per share is Rs 2.

Balaji Telefilms said that its board approved a composite scheme of arrangement between the company and its two wholly-owned subsidiaries -- Balaji Motion Pictures (BMPL) and Bolt Media (Bolt). As per the scheme, BMPL will demerge its film production undertaking and merge it with Balaji Telefilms. Further, Bolt will amalgamate with Balaji Telefilms. The scheme will streamline business structure, consolidate operations and reduce costs. The scheme does not involve any cash consideration, the company said in a statement.

BMPL is engaged in inter alia the business of production and distribution of motion pictures and films. Post demerger of its film production undertaking, BMPL will focus on the business of film distribution.

Bolt is engaged in inter alia the business of production of non-fiction, fiction, reality, factual television shows, event management, branded entertainment, digital content, consultancy and creative services related to it.

On a consolidated basis, net profit of Balaji Telefilms declined 84.27% to Rs 0.67 crore on 56.02% rise in net sales to Rs 116.45 crore in Q1 June 2016 over Q1 June 2015.

Balaji Telefilms is Indias leading integrated media conglomerate with market leadership in the television content industry, among other entertainment-led businesses.

Powered by Capital Market - Live News

RBL Bank gains after raising Rs 330 crore from CDC Group
Sep 28,2016

The announcement was made after market hours yesterday, 27 September 2016.

Meanwhile, the BSE Sensex was up 62.31 points, or 0.22%, to 28,286.01

On BSE, so far 39,000 shares were traded in the counter, compared with average daily volume of 1.78 lakh shares in the past two weeks. The stock hit a high of Rs 304.25 and a low of Rs 300.90 so far during the day. The stock hit a record high of Rs 316.80 on 1 September 2016. The stock hit a record low of Rs 273.70 on 31 August 2016. Shares of RBL Bank were listed on the stock exchanges on 31 August 2016. The stock debuted at Rs 273.70, a premium of 21.64% to the initial public offer (IPO) price of Rs 225 per share. On that day, it settled at Rs 299.30 on BSE, a premium of 33.02% over the IPO price.

The large-cap private sector bank has equity capital of Rs 369.81 crore. Face value per share is Rs 10.

RBL Bank said that the Tier II debt will strengthen the capital base of the bank, which in turn will support its businesses such as SME lending, agribusiness financing and financial inclusion. The infusion will also help the bank expand to new regions within India, the bank said.

RBL Banks net profit rose 41.17% to Rs 292.49 crore on 36.46% growth in net total income to Rs 1309.75 crore in the year ended 31 March 2016 (FY 2016) over the year ended 31 March 2015 (FY 2015).

RBL Bank is professionally managed and has no identifiable promoter. As on 31 March 2016, the bank had 197 interconnected branches and 362 interconnected ATMs spread across 16 Indian states and union territories serving approximately 1.90 million customers.

Powered by Capital Market - Live News

IL&FS Transportation jumps after Sebi nod for investment trust
Sep 28,2016

The announcement was made after market hours yesterday, 27 September 2016.

Meanwhile, the BSE Sensex was up 34.48 points, or 0.12%, to 28,258.18.

On BSE, so far 1.62 lakh shares were traded in the counter, compared with average daily volume of 2.71 lakh shares in the past one quarter. The stock hit a high of Rs 106.40 and a low of Rs 100.50 so far during the day. The stock hit a 52-week high of Rs 109.05 on 21 September 2016. The stock hit a record low of Rs 64 on 26 February 2016. The stock had outperformed the market over the past 30 days till 27 September 2016, rising 41.14% compared with 1.15% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 37.94% as against Sensexs 5.55% rise.

The mid-cap company has equity capital of Rs 328.96 crore. Face value per share is Rs 10.

IL&FS Transportation Networks said that the Securities & Exchange Board of India (Sebi) has vide its letter dated 27 September 2016 granted in-principle approval for registration of IL&FS Transportation Investment Trust as Infrastructure Investment Trust under the SEBI (Infrastructure Investment Trusts) Regulations, 2014 subject to compliance of certain conditions. The company will act as the sponsor of trust once it is registered.

IL&FS Transportation Networks reported net profit of Rs 17.87 crore in Q1 June 2016 as against net loss of Rs 18.64 crore in Q1 June 2015. Net sales rose 3.55% to Rs 937.46 crore in Q1 June 2016 over Q1 June 2015.

IL&FS Transportation Networks has grown into the largest BOT (build, operate and transfer) road assets owner in India.

Powered by Capital Market - Live News

Karur Vysya Bank gains on stock split plan
Sep 28,2016

The announcement was made after market hours yesterday, 27 September 2016.

Meanwhile, the BSE Sensex was up 36.66 points, or 0.13%, to 28,260.36.

On BSE, so far 812 shares were traded in the counter, compared with average daily volume of 24,813 shares in the past one quarter. The stock hit a high of Rs 476 and a low of Rs 473 so far during the day. The stock hit a 52-week high of Rs 541.40 on 11 July 2016. The stock hit a 52-week low of Rs 393.90 on 29 February 2016. The stock had underperformed the market over the past 30 days till 27 September 2016, falling 5.58% compared with 1.15% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 6.98% as against Sensexs 5.55% rise.

The mid-cap private sector bank has equity capital of Rs 121.86 crore. Face value per share is Rs 10.

Karur Vysya Bank said it has sought shareholders approval for a proposal of splitting each share into five shares (5-for-1). Shareholders will vote for the proposal through a postal ballot process.

Karur Vysya Banks net profit rose 8.7% to Rs 146.35 crore on 1.9% rise in operating income to Rs 1547.31 crore in Q1 June 2016 over Q1 June 2015.

Karur Vysya Bank has 667 branches and 1655 ATMs as on 31 March 2016.

Powered by Capital Market - Live News

Motherson Sumi Systems gains after RBI hikes FPIs investment limit
Sep 28,2016

The Reserve Bank of India (RBI) made the announcement after market hours yesterday, 27 September 2016.

Meanwhile, the BSE Sensex was up 46.99 points, or 0.17%, to 28,270.69.

On BSE, so far 3,568 shares were traded in the counter, compared with average daily volume of 2.73 lakh shares in the past one quarter. The stock hit a high of Rs 318.55 and a low of Rs 317 so far during the day. The stock hit a 52-week high of Rs 358.55 on 2 August 2016. The stock hit a 52-week low of Rs 206.20 on 25 February 2016. The stock had underperformed the market over the past 30 days till 27 September 2016, falling 3.22% compared with 1.15% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 13.28% as against Sensexs 5.55% rise.

The large-cap company has equity capital of Rs 140.35 crore. Face value per share is Re 1.

RBI notified that foreign institutional investors (FIIs)/registered foreign portfolios investors (RFPIs) can under the portfolio investment scheme (PIS) now invest upto 30% of the paid up capital of Motherson Sumi Systems. The purchases could be made through primary market and stock exchanges. RBI stated that the companys board of directors and its shareholders approved enhancing the limit for the purchase of its equity shares by FIIs/RFPIs.

Motherson Sumi Systems consolidated net profit rose 15.8% to Rs 439.36 crore on 16.1% increase in net sales to Rs 10352.33 crore in Q1 June 2016 over Q1 June 2015.

Motherson Sumi Systems is one of the worlds fastest growing specialized automotive component manufacturing company for original equipment manufacturers (OEMs). It is a joint venture between Samvardhana Motherson Group and Sumitomo Wiring Systems (Japan).

Powered by Capital Market - Live News

Narayana Hrudayalaya scales record high after bulk deal
Sep 27,2016

Meanwhile, the S&P BSE Sensex was down 70.58 points or 0.25% at 28,223.70.

Bulk deal boosted volume on the scrip. On BSE, so far 13.76 lakh shares were traded in the counter as against average daily volume of 8,033 shares in the past one quarter. The stock hit a high of Rs 373 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 325 so far during the day. The stock had hit a record low of Rs 272.20 on 29 March 2016. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 5.49% compared with 1.84% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, gaining 3.43% as against Sensexs 6.67% rise.

The mid-cap company has equity capital of Rs 204.36 crore. Face value per share is Rs 10.

Narayana Hrudayalaya reported consolidated net profit of Rs 16.72 crore in Q1 June 2016 as compared with net loss of Rs 0.51 crore in Q1 June 2015. Net sales rose 17.76% to Rs 442.32 crore in Q1 June 2016 over Q1 June 2015.

Headquartered in Bengaluru, Narayana Hrudayalaya operates a chain of 23 hospitals, 8 heart centres and 24 primary care facilities across India. The hospitals provide advanced levels of care in over 30 specialties, including cardiology, cardiac surgery, cancer care, neurology, neurosurgery, orthopaedics, nephrology, urology and gastroenterology. The company is currently in the process of commissioning a dedicated paediatric hospital in Mumbai and a multispecialty hospital at Lucknow in Uttar Pradesh.

Powered by Capital Market - Live News

NIIT gains after acquisition
Sep 27,2016

The announcement was made during trading hours today, 27 September 2016.

Meanwhile, the BSE Sensex was down 111.49 points, or 0.39%, to 28,182.79.

On BSE, so far 4.76 lakh shares were traded in the counter, compared with average daily volume of 3.72 lakh shares in the past one quarter. The stock hit a high of Rs 102.40 and a low of Rs 98 so far during the day. The stock hit a 52-week high of Rs 107.80 on 20 September 2016. The stock hit a 52-week low of Rs 67.55 on 12 February 2016. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 3.39% compared with 1.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 18.53% as against Sensexs 6.67% rise.

The small-cap company has equity capital of Rs 33.13 crore. Face value per share is Rs 2.

NIIT said that the strategic acquisition will bring together complementary technology platforms and capabilities of NIIT and Perceptron Learning Solutions, enabling NIIT to further accelerate its Digital Transformation initiatives n++ StackRoute, digiNxt, and Training.com.

Ilimi which is Perceptrons next-gen learning platform combines leading edge developments in semantic computing, predictive analytics, learning science, and digital transformation technologies to create an environment for implementing learner-centric, immersive learning & mastery learning strategies.

Perceptrons acquisition builds on NIITs strategic focus for a leadership role in the Digital Learning world. Together with existing platforms, this will become an integral part of NIITs future multi-modal learning platform and 360 degree learning eco-system. Further, Perceptrons co-founders and engineering team will strengthen NIITs technology talent pool with their proven expertise.

On a consolidated basis, net profit of NIIT declined 50.67% to Rs 7.40 crore on 11.66% rise in net sales to Rs 260.40 crore in Q1 June 2016 over Q1 June 2015.

NIIT, a global leader in skills and talent development, offers multi-disciplinary learning management and training delivery solutions to corporations, institutions, and individuals in over 40 countries. NIIT has three main lines of business across the globe-corporate learning group, skills and careers group, and school learning group.

Powered by Capital Market - Live News

Vivimed Labs hits roof after block deal
Sep 27,2016

Meanwhile, the BSE Sensex was up 5.62 points, or 0.02%, to 28,299.90.

On BSE, so far 22.18 lakh shares were traded in the counter, compared with average daily volume of 69,351 shares in the past one quarter. The stock was currently frozen at the record high level for the counter. The stock hit a low of Rs 86.75 in intraday trade. The stock hit a 52-week low of Rs 58.40 on 28 September 2015. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 16% compared with 1.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.31% as against Sensexs 6.67% rise.

The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 2.

On a consolidated basis, Vivimed Labs net profit rose 15.27% to Rs 27.86 crore on 10.65% growth in net sales to Rs 366.83 crore in Q1 June 2016 over Q1 June 2015.

Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.

Powered by Capital Market - Live News

Kiri Inds gains as board to consider allotment of warrants to promoter group firm
Sep 27,2016

The announcement was made during market hours today, 27 September 2016.

Meanwhile, the S&P BSE Sensex was up 31.11 points or 0.11% at 28,325.39

On BSE, so far 65,000 shares were traded in the counter as against average daily volume of 1.43 lakh shares in the past one quarter. The stock hit a high of Rs 357.75 and a low of Rs 348 so far during the day. The stock had hit a 52-week high of Rs 404.75 on 1 July 2016. The stock had hit a 52-week low of Rs 72.10 on 11 February 2016. The stock had underperformed the market over the past 30 days till 26 September 2016, rising 1.65% compared with 1.84% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 8.46% as against Sensexs 6.67% rise.

The small-cap company has equity capital of Rs 27.84 crore. Face value per share is Rs 10.

Kiri Industries said that a meeting of the board of directors of the company will be held on 4 October 2016, to allot 35 lakh warrants to Equinaire Chemtech LLP, a promoter group firm at Rs 363 per warrant on preferential basis.

On consolidated basis, Kiri Industries net profit rose 15.5% to Rs 80.99 crore on 51.17% rise in net sales to Rs 289.30 crore in Q1 June 2016 over Q1 June 2015.

Kiri Industries is one of the largest manufacturer and exporter of wide range of dyes, intermediates and chemicals.

Powered by Capital Market - Live News

Marksans Pharma spurts 14% in two sessions
Sep 27,2016

Meanwhile, the BSE Sensex was up 26.13 points, or 0.09%, to 28,320.41.

On BSE, so far 29.25 lakh shares were traded in the counter, compared with average daily volume of 7.73 lakh shares in the past one quarter. The stock hit a high of Rs 55.55 and a low of Rs 53.15 so far during the day. The stock hit a 52-week high of Rs 113.80 on 28 December 2015. The stock hit a 52-week low of Rs 33.45 on 1 March 2016. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 29.74% compared with 1.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 14.84% as against Sensexs 6.67% rise.

The small-cap company has equity capital of Rs 40.93 crore. Face value per share is Re 1.

Marksans Pharma announced during market hours yesterday, 26 September 2016, that US Food and Drug Administration (USFDA) has granted approval to the company for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filled capsules 10 mg. Loratadine liquid filled capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC. Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching and other allergy symptoms.

Shares of Marksans Pharma spurted 10.76% to settle at Rs 53 yesterday, 26 September 2016. The stock has risen 14% in two sessions from its close of Rs 47.85 on Friday, 23 September 2016.

Marksans Pharmas consolidated net profit fell 96.76% to Rs 1.02 crore on 11.14% fall in net sales to Rs 186.75 crore in Q1 June 2016 over Q1 June 2015.

Marksans Pharma is engaged in research, manufacturing and marketing of generic pharmaceutical formulation in the global market.

Powered by Capital Market - Live News

Adlabs Entertainment corrects on profit booking
Sep 27,2016

Meanwhile, the BSE Sensex was up 85.50 points, or 0.30%, to 28,379.78.

On BSE, so far 4.78 lakh shares were traded in the counter, compared with average daily volume of 1.35 lakh shares in the past one quarter. The stock hit a high of Rs 112.80 and a low of Rs 106.10 so far during the day. The stock hit a 52-week high of Rs 145.40 on 31 December 2015. The stock hit a record low of Rs 68 on 29 February 2016. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 43.57% compared with 1.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 48.22% as against Sensexs 6.67% rise.

The small-cap company has equity capital of Rs 79.90 crore. Face value per share is Rs 10.

Shares of Adlabs Entertainment rose 45.71% in four trading sessions to settle at Rs 112.20 yesterday, 26 September 2016, from its close of Rs 77 on 20 September 2016.

Adlabs Entertainment reported net loss of Rs 19.23 crore in Q1 June 2016, higher than net loss of Rs 15.52 crore in Q1 June 2015. Net sales rose 7.3% to Rs 83.10 crore in Q1 June 2016 over Q1 June 2015.

Adlabs Entertainment operates the Imagica theme park located at Khalapur, off the Mumbai-Pune express highway.

Powered by Capital Market - Live News

MCX spurts after raising transaction fee
Sep 27,2016

The company made the announcement ysterday, 26 September 2016.

Meanwhile, the BSE Sensex was up 98.71 points, or 0.35%, to 28,392.99.

On BSE, so far 3.93 lakh shares were traded in the counter, compared with average daily volume of 49,502 shares in the past one quarter. The stock hit a high of Rs 1,181.35 so far during the day, which is also a 52-week high for the counter. The stock hit a low of Rs 1,075 so far during the day. The stock hit a 52-week low of Rs 726 on 12 February 2016. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 8.76% compared with 1.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 7.18% as against Sensexs 6.67% rise.

The mid-cap commodity exchange has equity capital of Rs 51 crore. Face value per share is Rs 10.

For trading in non-agricultural commodities, Multi Commodity Exchange of India (MCX) has increased the transaction fee to Rs 2.60 for every Rs 1 lakh turnover for members generating a monthly average daily turnover of up to Rs 350 crore. Incremental turnover above Rs 350 crore would attract a charge of Rs 1.75 per lakh. In the case of agriculturural commodities, MCX has increased the transaction charges to Rs 1.75 for every Rs 1 lakh turnover.

The transaction fee shall be debited on a monthly basis to the settlement account of the members in the first week of the succeeding month. The above said transaction fee structure will be effective for trades executed from 1 October 2016 onwards and will be valid till further notice.

Earlier on 26 February 2014, MCX had slashed transaction charges. MCX charged 75 paise for every Rs 1 lakh turnover for members generating a monthly average daily turnover of up to Rs 20 crore for trading in agricultural commodities. Incremental turnover above Rs 20 crore attracted a charge of 50 paise per lakh. In the case of non-agriculturural commodities, MCX charged Rs 2.10 for every Rs 1 lakh turnover, for members generating average daily turnover of up to Rs 350 crore, and Rs 1.40 per lakh on incremental turnover above Rs 350 crore.

MCXs net profit rose 54.5% to Rs 32.81 crore on 12.5% rise in net sales to Rs 58.23 crore in Q1 June 2016 over Q1 June 2015.

MCX is Indias first listed, national-level, electronic, commodity futures exchange with permanent recognition from the Government of India.

Powered by Capital Market - Live News

Maithan Alloys drops after intimating about damage at Visakhapatnam plant
Sep 27,2016

The announcement was made after market hours yesterday, 26 September 2016.

Meanwhile, the S&P BSE Sensex was up 84.62 points, or 0.3% to 28,378.90

On BSE, so far 22,000 shares were traded in the counter as against an average daily volume of 21,749 shares in the past one quarter. The stock hit a high of Rs 250.50 and a low of Rs 210.20 so far during the day. The stock had hit a 52-week high of Rs 434.50 on 8 August 2016. The stock hit 52-week low of Rs 77 on 1 October 2015. The stock had underperformed the market over the past 30 days till 26 September 2016, falling 11.43% compared with 1.84% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 1.29% as against Sensexs 6.67% rise.

The small-cap company has equity capital is Rs 29.11 crore. Face value per share is Rs 10.

Maithan Alloys said that due to heavy rains and flood, there has been severe damage to 132 kilovolt (KV) power transformer and other electrical equipment installed at the companys Visakhapatnam plant. The full damage is yet to be ascertained, Maithan Alloys said. The transformer and other electrical equipment are fully insured, the company said. The production at the plant could be significantly affected over the next few months, it added.

Maithan Alloys net profit rose 132.57% to Rs 18.28 crore on 36.14% growth in net sales to Rs 251.77 crore in Q1 June 2016 over Q1 June 2015.

Maithan Alloys operates in the niche value-added manganese alloy segment.

Powered by Capital Market - Live News

Indoco Remedies slides on reports of getting six USFDA observations for Goa Plants
Sep 27,2016

Meanwhile, the BSE Sensex was up 74.40 points, or 0.26%, to 28,368.68.

On BSE, so far 43,000 shares were traded in the counter, compared with average daily volume of 9,498 shares in the past one quarter. The stock hit a high of Rs 328 and a low of Rs 312.40 so far during the day. The stock hit a 52-week high of Rs 360.35 on 7 September 2016. The stock hit a 52-week low of Rs 244 on 25 February 2016. The stock had outperformed the market over the past 30 days till 26 September 2016, rising 10.76% compared with 1.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 26.18% as against Sensexs 6.67% rise.

The mid-cap company has equity capital of Rs 18.43 crore. Face value per share is Rs 2.

According to reports, Indoco Remedies Goa Plant II and III were inspected by US Food and Drug Administration (USFDA) from 31 August 2016 to 4 September 2016. Six observations cover quality, production systems, facilities and equipment, and customer complaints.

The companys Goa Plant II is a sterile facility for ophthalmics and injectables approved by USFDA for ophthalmic preparations. The companys Goa Plant III has a capability to manufacture aqueous, non-aqueous and photo sensitive products.

Reports added that the companys Goa Plant II is important as most ophthalmic Abbreviated New Drug Applications (ANDAs) are filed from here.

Indoco Remedies net profit declined 4.9% to Rs 19.79 crore on 15.8% rise in net sales to Rs 252.72 crore in Q1 June 2016 over Q1 June 2015.

Indoco Remedies is a fully integrated, research-oriented pharma vompany with presence in 55 countries.

Powered by Capital Market - Live News